Search
Travere Therapeutics Inc
TVTXAdd to Watchlist
56.920USD
+0.580+1.03%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
5.18BMarket Cap
LossP/E TTM
Travere Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Travere Therapeutics Inc is 9.84, ranking 9 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -254.54, which is -99.33% below the recent high of -1.70 and -3.71% above the recent low of -263.97.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.